Impella 5.5 Support for Delayed Surgical Ventricular Septal Defect Repair-A Paradigm Shift?

Area of Science:

• Cardiovascular Surgery
• Interventional Cardiology
• Mechanical Circulatory Support

Background:

• Ventricular septal defects (VSDs) are rare, life-threatening myocardial infarction complications with high mortality.
• Mechanical circulatory support (MCS) for VSD repair is understudied, with Impella often considered contraindicated.
• Timely VSD repair is critical, but tissue stabilization may benefit from delayed intervention.

Purpose of the Study:

• To evaluate the safety and feasibility of using Impella 5.5 as a primary mechanical circulatory support for patients undergoing VSD repair.
• To analyze outcomes in patients with VSD who received Impella 5.5 support prior to surgical repair.

Main Methods:

• Retrospective analysis of four consecutive patients with VSD undergoing delayed surgical repair after Impella 5.5 implantation.
• Data collected on patient presentation, Impella implantation procedure, and postoperative course.

Main Results:

• 75% of patients presented with acute right heart failure and elevated pulmonary artery pressure.
• Impella 5.5 implantation was performed under local anesthesia in most cases.
• Successful weaning from Impella 5.5 occurred in 75% of patients, with a mean intensive care unit stay of 22.3 days.

Conclusions:

• Preoperative Impella 5.5 implantation is a safe and feasible option for VSD repair patients.
• Local anesthesia and continued Impella support post-repair may improve outcomes.
• Despite potential benefits, VSD patients remain high-risk with a significant mortality rate.